SSDDS and Novartis Saudi have entered a strategic partnership to enhance medical education, disease awareness, and patient care pathways for Chronic Urticaria across Saudi Arabia.
The Saudi Society of Dermatology and Dermatologic Surgery (SSDDS) and Novartis Saudi have announced a strategic collaboration aimed at advancing medical education and improving the patient care journey for individuals living with Chronic Urticaria (CU) in Saudi Arabia.
Also Read: Royal Pharmacy Kuwait Launches New eCommerce Platform and Mobile Apps
Formalised through the signing of a Letter of Intent, the partnership seeks to strengthen Chronic Urticaria care pathways across the Kingdom by promoting evidence-based medical education, increasing disease awareness, and supporting more informed and structured patient journeys. The initiative aligns with SSDDS’s mandate to advance dermatologic practice and professional development nationwide, while reinforcing Novartis Saudi’s continued focus on patient-centred care within the field of immuno-dermatology.
Commenting on the collaboration, Dr. Abdullah Suleiman Al-Akeel, President of the Saudi Society of Dermatology and Dermatologic Surgery, said: “Advancing dermatologic care in Saudi Arabia requires continuous education, scientific exchange, and a strong focus on patient needs. Our collaboration with Novartis provides an important platform to enhance awareness and understanding of Chronic Urticaria among dermatologists and the wider healthcare community, in line with our mission to elevate standards of care nationwide.”
Amir Abdelaziz, Country President at Novartis Saudi Arabia, added: “Novartis has a long-standing leadership in immuno-dermatology, and our commitment to Saudi Arabia goes beyond providing treatments. As part of our mission to reimagine medicine, we are dedicated to transforming the patient journey. Through this collaboration with SSDDS, we aim to empower patients with accessible knowledge and support, ensuring that their path from the first flare-up to a specialized diagnosis is as informed and seamless as possible.”
Emphasizing the clinical impact of improved education, Dr. Dana Alessa, Head of Scientific Committee of the Saudi Society of Dermatology and Dermatologic Surgery, said: “Chronic urticaria is a condition that can be deeply distressing for patients, yet it often remains under-recognized or misunderstood. Through education, local evidence generation, and collaboration with leading medical societies, we aim to support earlier diagnosis, more informed clinical decision-making, and ultimately better quality of life for patients across the Kingdom.”
